Corvus Pharmaceuticals Inc sell tbackenh
Start price
02.02.26
/
50%
€17.52
Target price
02.03.26
-
Performance (%)
-10.27%
Price
06.02.26
€15.74
Summary
This prediction is currently active. The prediction for Corvus Pharmaceuticals Inc shows a convincing performance of -10.27%. This prediction currently runs until 02.03.26. The prediction end date can be changed by tbackenh at any time. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | - |
| iShares Core DAX® | 1,93 % |
| iShares Nasdaq 100 | -0,18 % |
| iShares Nikkei 225® | 7,08 % |
| iShares S&P 500 | -0,20 % |
According to tbackenh what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Cons
High valuation
Very low/no dividend yield expected
Lower EBIT Margin than peer group
Higher risks for its business
Comments by tbackenh for this prediction
Stopped prediction by tbackenh for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-22.69%
22.10.21
22.10.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
High valuation
